Literature DB >> 19773593

Systemic inflammatory response syndrome in nonhuman primates culminating in multiple organ failure, acute lung injury, and disseminated intravascular coagulation.

Renee R Hukkanen1, H Denny Liggitt, Robert D Murnane, Charles W Frevert.   

Abstract

The systemic inflammatory response syndrome (SIRS) is a clinicopathological manifestation of overexuberant acute-phase inflammation caused by infectious or noninfectious etiologies. The systemic release of pro-inflammatory cytokines, chemokines, and lipid and vasoactive mediators induces endothelial damage and microvascular thrombosis, potentially culminating in disseminated intravascular coagulation (DIC), acute respiratory distress syndrome (ARDS), and multiple organ dysfunction (MOD) or failure (MOF). We present five cases in the pig-tailed macaque and olive baboon where SIRS resulted in MOF, ARDS, DIC, and the Waterhouse-Friderichsen syndrome; each with gross and histological elements manifested as edema, deposition of fibrin, hemorrhage, and thrombosis. In the described cases, SIRS was the end-common pathway for multiple risk factors that parallel those documented in humans: major surgery, obstetric complications, and infection. The diagnosis of SIRS should be considered when evaluating nonhuman primate (NHP) cases of MOF manifesting with histological evidence of vascular leakage. Experimental manipulation of NHP models may be complicated by SIRS and accompanying rapid clinical decompensation. Such adverse events may compromise toxicological studies and should be avoided when possible.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19773593      PMCID: PMC4113424          DOI: 10.1177/0192623309343778

Source DB:  PubMed          Journal:  Toxicol Pathol        ISSN: 0192-6233            Impact factor:   1.902


  12 in total

1.  Spontaneous Waterhouse-Friderichsen syndrome in a gang-housed baboon.

Authors:  M Cary; S Kosanke; G White
Journal:  J Med Primatol       Date:  2001-06       Impact factor: 0.667

2.  Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care.

Authors:  D C Angus; W T Linde-Zwirble; J Lidicker; G Clermont; J Carcillo; M R Pinsky
Journal:  Crit Care Med       Date:  2001-07       Impact factor: 7.598

Review 3.  Commentary. The uncontrolled variable in risk assessment: ad libitum overfed rodents--fat, facts and fiction.

Authors:  K P Keenan
Journal:  Toxicol Pathol       Date:  1996 May-Jun       Impact factor: 1.902

Review 4.  Pathophysiology of ischaemia-reperfusion injury.

Authors:  D L Carden; D N Granger
Journal:  J Pathol       Date:  2000-02       Impact factor: 7.996

5.  Identification of high and low responders to lipopolysaccharide in normal subjects: an unbiased approach to identify modulators of innate immunity.

Authors:  Mark M Wurfel; William Y Park; Frank Radella; John Ruzinski; Andrew Sandstrom; Jeanna Strout; Roger E Bumgarner; Thomas R Martin
Journal:  J Immunol       Date:  2005-08-15       Impact factor: 5.422

6.  Staphylococcus aureus sepsis and the Waterhouse-Friderichsen syndrome in children.

Authors:  Patricia V Adem; Christopher P Montgomery; Aliya N Husain; Tracy K Koogler; Valerie Arangelovich; Michel Humilier; Susan Boyle-Vavra; Robert S Daum
Journal:  N Engl J Med       Date:  2005-09-22       Impact factor: 91.245

Review 7.  Systemic inflammatory response syndrome (SIRS): molecular pathophysiology and gene therapy.

Authors:  Naoyuki Matsuda; Yuichi Hattori
Journal:  J Pharmacol Sci       Date:  2006-07-06       Impact factor: 3.337

Review 8.  Compartmentalization of the inflammatory response in sepsis and SIRS.

Authors:  Jean-Marc Cavaillon; Djillali Annane
Journal:  J Endotoxin Res       Date:  2006

Review 9.  Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine.

Authors:  R C Bone; R A Balk; F B Cerra; R P Dellinger; A M Fein; W A Knaus; R M Schein; W J Sibbald
Journal:  Chest       Date:  1992-06       Impact factor: 9.410

10.  Aortic aneurysms, inflammatory pathways and nitric oxide.

Authors:  R D Sayers
Journal:  Ann R Coll Surg Engl       Date:  2002-07       Impact factor: 1.891

View more
  12 in total

1.  Pathology of Aging in NOD scid gamma Female Mice.

Authors:  Sara F Santagostino; Rodolfo J Ricart Arbona; Melissa A Nashat; Julie R White; Sebastien Monette
Journal:  Vet Pathol       Date:  2017-03-29       Impact factor: 2.221

2.  Application of bedside continuous blood purification in patients with multiple organ dysfunction syndromes.

Authors:  Hai-Bo Liu; Min Zhang; Jing-Xiao Zhang; Yong-Jie Yin
Journal:  World J Emerg Med       Date:  2012

3.  Controlling the cytokine storm in severe bacterial diarrhoea with an oral Toll-like receptor 4 antagonist.

Authors:  Dilara Islam; Eric Lombardini; Nattaya Ruamsap; Rawiwan Imerbsin; Patchariya Khantapura; Ian Teo; Pimmnapar Neesanant; Siriphan Gonwong; Kosol Yongvanitchit; Brett E Swierczewski; Carl J Mason; Sunil Shaunak
Journal:  Immunology       Date:  2015-11-24       Impact factor: 7.397

4.  Continuous regional arterial infusion with fluorouracil and octreotide attenuates severe acute pancreatitis in a canine model.

Authors:  Meng Tao Zhou; Bi Cheng Chen; Hong Wei Sun; Yue Peng Jin; Fa Jing Yang; Xing Zhang; Roland Andersson; Qi Yu Zhang
Journal:  PLoS One       Date:  2012-05-24       Impact factor: 3.240

5.  Xuebijing exerts protective effects on lung permeability leakage and lung injury by upregulating Toll-interacting protein expression in rats with sepsis.

Authors:  Ming-Wei Liu; Yun-Hui Wang; Chuan-Yun Qian; Hui Li
Journal:  Int J Mol Med       Date:  2014-09-23       Impact factor: 4.101

6.  Regional arterial infusion with lipoxin A4 attenuates experimental severe acute pancreatitis.

Authors:  Fajing Yang; Jianming Xie; Weiming Wang; Yangyun Xie; Hongwei Sun; Yuepeng Jin; Dan Xu; Bicheng Chen; Roland Andersson; Mengtao Zhou
Journal:  PLoS One       Date:  2014-09-29       Impact factor: 3.240

7.  Maraviroc-Mediated Lung Protection following Trauma-Hemorrhagic Shock.

Authors:  Fu-Chao Liu; Chih-Wen Zheng; Huang-Ping Yu
Journal:  Biomed Res Int       Date:  2016-07-31       Impact factor: 3.411

8.  Hypoxia-induced endothelial damage and microthrombosis in myocardial vessels of newborn landrace/large white piglets.

Authors:  Armando Faa; Theodoros Xanthos; Vassilios Fanos; Daniela Fanni; Clara Gerosa; Pietro Pampaloni; Maria Elena Pais; Gavino Faa; Nicoletta Iacovidou
Journal:  Biomed Res Int       Date:  2014-03-04       Impact factor: 3.411

9.  Urokinase-type plasminogen activator receptor as a predictor of poor outcome in patients with systemic inflammatory response syndrome.

Authors:  Xiao-Ling Wu; Ding Long; Li Yu; Jun-Hui Yang; Yuan-Chao Zhang; Feng Geng
Journal:  World J Emerg Med       Date:  2013

10.  Host responses to concurrent combined injuries in non-human primates.

Authors:  Matthew J Bradley; Diego A Vicente; Benjamin A Bograd; Erin M Sanders; Crystal L Leonhardt; Eric A Elster; Thomas A Davis
Journal:  J Inflamm (Lond)       Date:  2017-11-02       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.